<DOC>
	<DOC>NCT00213070</DOC>
	<brief_summary>The purpose of this study is evaluate the clinical efficacy and safety of Miglitol in patients with Type2 Diabetes Mellitus with treated insulin.</brief_summary>
	<brief_title>Double-Blind Trial of Miglitol in Type 2 Diabetic Patients With Insulin Treatment</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Miglitol</mesh_term>
	<criteria>Type2 diabetes Criteria of postprandial plasma glucose and HbA1c are met Type1 diabetes Patients with antidiabetic drugs The other exclusion criteria are met</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2006</verification_date>
	<keyword>alpha-glucosidase inhibitor,Insulin</keyword>
</DOC>